Real-World Data on Maintenance Avelumab Treatment
The JAVELIN Bladder 100 trial showed a survival benefit for maintenance avelumab following platinum-based chemotherapy in metastatic/locally advanced urothelial carcinoma. This study aimed to provide further insights into real-world outcomes and progression-free survival for patients treated with avelumab, presented in this MEDtalk by Dr. Rehan.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
